Federal Supply Schedule 36F79722D0182
Award Date 8/15/22
Last Date to Order 8/14/27
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed Similar IDVs
- This Federal Supply Schedule contract was awarded by the U.S. Department of Veterans Affairs to Optinose US, Inc. for the procurement of drugs, pharmaceuticals, and hematology-related products. The contract has a total ceiling value of $17,220,510.00 and a period of performance from July 1, 2023 to June 30, 2028. The contract is a multiple award vehicle, meaning it allows for task orders to be issued to Optinose US, Inc. and potentially other qualified vendors. The scope of the contract covers a...
- Insmed Inc., a global biopharmaceutical company headquartered in Bridgewater, New Jersey, was awarded a Multiple Award Federal Supply Schedule (FSS) contract on June 1, 2024, by the Department of Veterans Affairs National Acquisition Center under Schedule 65 IB for Drugs, Pharmaceuticals, and Hematology Related Products. The contract carries a ceiling value of $24.15 million with a performance period extending through May 31, 2029. This FSS vehicle enables the VA to issue delivery orders for a...
- The Department of Veterans Affairs (VA) has awarded Acorda Therapeutics, Inc., a biotechnology company specializing in neurological therapies, an IDV Federal Supply Schedule contract (36F79723D0194) valued at over $16.3 million. This multiple-award contract covers the procurement of drugs, pharmaceuticals, and hematology-related products through September 2028. Under this IDV, the VA Veterans Integrated Service Network 12 has issued firm fixed-price delivery orders for Acorda's Levodopa 42mg...
- The Department of Veterans Affairs National Acquisition Center awarded a single-award indefinite delivery contract to Glenmark Pharmaceuticals Inc., USA to supply Zolmitriptan orally disintegrating and tablet formulations. The contract has a potential value of $1,734,148.80 over a one-year base period and four one-year option periods extending to January 2023. The original solicitation sought unrestricted offers for an uninterrupted supply of Zolmitriptan to support the pharmaceutical needs of...
- The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Medstone Pharma, LLC for the delivery of Zolmitriptan Tablets. The contract has a base year from December 30, 2024 to December 29, 2025, with four one-year option periods, for a total ceiling value of $8,942,988.48. The contracting vehicle will be used to provide Zolmitriptan tablets to the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and...
- Tris Pharma Inc. (UEI: NVJMJ89DAG58) was awarded a multiple-award Federal Supply Schedule contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule on September 1, 2023, with a ceiling value of $28,000,000 and an ultimate completion date of August 31, 2028. This indefinite delivery vehicle was awarded without set-asides by the Veterans Integrated Service Network 12, a civilian agency within the Department of Veterans Affairs. The contract covers the supply of drugs, pharmaceuticals,...
- The Department of Veterans Affairs National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Medstone Pharma LLC, a for-profit limited liability company, on December 30, 2019. The contract has a potential value of $4,951,441.25 and covers the procurement of Zolmitriptan tablets, both orally disintegrating and regular, for the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. The contract includes a base year of performance from December 30,...
- This Federal Supply Schedule contract was awarded to Theranica USA, Inc. (UEI: F1FEK1PTFTT1) on February 15, 2021, under the General Services Administration's Medical Equipment and Supplies schedule (FSS-65-II-A). The contract, which is a multiple-award indefinite delivery vehicle without set-asides, is funded by the Veterans Integrated Service Network 12, a civilian agency within the Department of Veterans Affairs. The contract carries a ceiling value of $2.25 million with an ultimate...
- This is a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Aprecia Pharmaceuticals Company, a manufacturer of pharmaceutical goods. The contract is for the provision of drugs, pharmaceuticals, and hematology-related products under FSS schedule 65 I B, with a contract ceiling value of $9,000,000 and a period of performance from March 1, 2017 to February 28, 2026. The contract is a multiple award vehicle, meaning it allows for orders to be placed...
- This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs, Veterans Integrated Service Network 12, to Aquestive Therapeutics, Inc., a for-profit manufacturer of goods and subchapter S corporation. The contract, which has a maximum value of $25,000.00 and a period of performance through March 31, 2025, provides for the delivery of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B of the Federal Supply Schedule. The contract is a multiple...
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order 36F79722D0182-36C24924F0083 | Impel Pharmaceuticals Inc. | $0 | 3/4/24 | 6/30/24 | 3/14/24 | |
Delivery Order 36F79722D0182-36C25224F0185 | Impel Pharmaceuticals Inc. | $3.8k | 6/10/24 | 7/31/24 | 6/10/24 | |
Delivery Order 36F79722D0182-36C25224F0068 | Impel Pharmaceuticals Inc. | $3.6k | 12/26/23 | 1/12/24 | 12/26/23 | |
Delivery Order 36F79722D0182-36C24924F0025 | Impel Pharmaceuticals Inc. | $3.7k | 10/17/23 | 11/16/23 | 10/17/23 |